title: Pregnancy in renal transplant recipients.
abstract: OBJECTIVE
  Renal transplantation with a well-functioning graft leads to a rapid restoration of endocrine and sexual functions. The aim of this study was to examine our experience with pregnancies among renal transplant patients, particularly with regard to their impact on graft function.
  
  
  METHODS
  We analyzed 10 pregnancies in 7 renal transplant recipients for long-term graft outcomes in terms of clinical and biological data.
  
  
  RESULTS
  The mean patient age was 28.5 +/- 4 years. They all received a living donor kidney. The time between transplantation and the onset of pregnancy was 33.4 +/- 23.2 months. Regarding the immunosuppressive therapy, all patients received steroids and cyclosporine; 4 patients received in addition azathioprine and 2 received mycophenolate mofetil that was changed at 1 month before conception to azathioprine. There was no significant difference between the serum creatinine before and during pregnancy. We did not observe any acute rejection episode. Pregnancy complications were preclampsia in 1 case, hypertension in 1 case, urinary tract infection in 2 cases, and anemia in 80% of patients during the third trimester. Premature rupture of membranes occurred in 1 case and preterm delivery in 2 cases. Two cases of neonatal death were registered. Cesarean section was performed in 50% of cases. The follow-up revealed 2 cases of chronic rejection.
  
  
  CONCLUSIONS
  A multidisciplinary approach is necessary for pregnancy which generally occurs at 2 years after kidney transplantation.
authors: Department of Nephrology, Unit of Nephrology-Dialysis-Renal, Rabat, Morocco.
authors: T
authors: T
authors: Bouattar
authors: H
authors: H
authors: Hakim
authors: H
authors: H
authors: Rhou
authors: L
authors: L
authors: Benamar
authors: R
authors: R
authors: Bayahia
authors: N
authors: N
authors: Ouzeddoun
mesh_terms: D000328:Adult; D000740:Anemia / Q000453:epidemiology; D002585:Cesarean Section / Q000706:statistics & numerical data; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D004927:Escherichia coli Infections / Q000453:epidemiology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D019520:Living Donors; D011247:Pregnancy; D011248:Pregnancy Complications / Q000145:classification / Q000453:epidemiology; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents; D003404:Creatinine